Delivery Order SPE2DB20D3103-SPE2DB25FN2N1

Award Date 3/28/25
Potential Completion Date 3/31/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,089.41 Firm Fixed Price Delivery Order is for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product. The contract has a period of performance through May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $1,289.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of CRYSELLE-28 TABLET 28S, a pharmaceutical product, to support military healthcare programs....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,556.30, is for the delivery of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a performance period through May 2, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,621.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,092.88 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for $2,307.00 and is a Firm Fixed Price Delivery Order contract to supply SKYLA 13.5 MG SYSTEMS medical products. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of medical supplies and medications. The contract, valued at $3,313.44, is a Firm Fixed Price Delivery Order that will be completed by August 20, 2024. The contract provides for the delivery of 4565511270 JUNEL FE 1MG-20MCG 168 units, a prescription contraceptive drug. The contract does not have a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,846,375.04 and is a firm fixed-price delivery order. The products being delivered under this contract include a wide range of pharmaceutical and medical products, such as prescription medications, medical devices, specialty pharmaceuticals, vaccines, and other healthcare-related...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $12,570.22, is for the delivery of pharmaceutical products including medications, medical supplies, and devices. The contract is a Firm Fixed Price Delivery Order with a completion date of February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $13,920.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of ORSERDU 345 MG TABLET 30S, a medical product, with a period of performance through February 4, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN2N1
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,153.66, is for the delivery of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a performance period through March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 6/27/25, 12:01 PM